ACTA1 and neoplasm: The administration of calcipotriol to an autochthonous PDAC mouse model (KPC model) resulted in the decreased expression of several iCAF and myCAF markers, such as IL-6 and α-SMA, accompanied by the increased tumor vascular area and chemosensitivity of the developed tumors.